Follow-On Offering: Our focus is on developing Ampion, which is a compound that decreases inflammation by inhibiting specific pro-inflammatory compounds.
Last Closing Price
June 17, 2019
FORDHAM FINANCIAL MANAGEMENT, INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Ampio Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277